Gamma-Aminobutyric Acid

Gamma-Aminobutyric Acid

SCHEMBL5795191

NCCCC(=O)O.O=C1CN=C(c2ccccc2)O1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.41
HDAC4 P56524 3/20 0.41
HDAC1 Q13547 3/20 0.41
HDAC7 Q8WUI4 3/20 0.41
HDAC2 Q92769 3/20 0.41
HDAC10 Q969S8 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
HDAC8 Q9BY41 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
HDAC9 Q9UKV0 3/20 0.41
HDAC5 Q9UQL6 3/20 0.41
LMNA P02545 2/20 0.41
THRB P10828 2/20 0.41
BLM P54132 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
TSHR P16473 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gamma-Aminobutyric Acid SCHEMBL2897912 0.76 KMT2A (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6135895 0.72 NPC1 (0.33) SMN1; SMN2
Phthalic Anhydride SCHEMBL10455461 0.71 HDAC3 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
Aminocaproic Acid SCHEMBL379308 0.71 ALDH1A1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
Gamma-Aminobutyric Acid SCHEMBL28119738 0.69 HDAC3 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
Gamma-Aminobutyric Acid SCHEMBL27860343 0.68 LMNA (0.88) HDAC3HDAC4HDAC1HDAC7HDAC2
Gamma-Aminobutyric Acid SCHEMBL29221604 0.67 HDAC3 (0.62) HDAC3HDAC4HDAC1HDAC7HDAC2
Biphenyl SCHEMBL29081077 0.66 FFAR1 (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
Gamma-Aminobutyric Acid SCHEMBL3017607 0.66 LMNA (0.83) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17512909 0.65 USP1 (0.37) LMNAGABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160082105-A1 Antibody Buffering of a Ligand in Vivo ARROWSMITH TECHNOLOGIES CORPORATION 2016-03-24 US disclosed
US-9173958-B2 Antibody buffering of a ligand in vivo ARROWSMITH TECHNOLOGIES CORPORATION (US) 2015-11-03 US disclosed
WO-2006036568-A9 ANTIBODY BUFFERING OF A LIGAND IN VIVO ARROWSMITH TECHNOLOGIES LLP (US) 2006-07-27 WO disclosed
US-20060062778-A1 Antibody buffering of a ligand in vivo ARROWSMITH TECHNOLOGIES CORPORATION 2006-03-23 US disclosed